A Phase 4 interventional study of Propranolol and Saline in Trauma, Brain, sponsored by Menoufia University. Completed at 1 site in Egypt. Open to participants aged 16 Years to 50 Years. Per ClinicalTrials.gov, last updated 2023-03-17.
Sponsored by Menoufia University · Phase 4, Interventional, and Supportive care
The study will be conducted on polytrauma patient who are admitted from emergency room or postoperative with head trauma to evaluate effects of beta blocker on patients with TBI.
The study will be conducted on polytrauma patient who are admitted from emergency room or postoperative with head trauma . Patients will be randomly assigned into two groups by sealed envelope technique into two equal groups.
Parameters assessment:
2,113 studies on the registry are indexed under Brain Injuries; 385 are open to participants now.
This study's enrollment of 40 is below the median of 48 across 1,331 interventional studies indexed under Brain Injuries.
Browse Brain Injuries studies →Menoufia University is the lead sponsor of 192 studies on the registry; 53 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Will be given Propranolol 1mg in 10 ml distilled water intravenous every 6 hours for 48 hours
Drug: Propranolol
Will be given normal saline 10 ml every 6 hours for 48 hours
Drug: Saline
intravenous propranolol for case patients
intravenous saline for placebo
survival
number of surviving in patients receiving propranolol and patients who did not receive any beta blocker
Time frame: 7 days
heart rate
number of patient showing effect of beta blocker on TBI related to HR
Time frame: 7 days
icu stay
number of patients were beta blocker in TBI affected on ICU and total hospital stay
Time frame: 7 days
Plan to share: Undecided
No publications or documents are linked to this record.
This study is completed, as verified in Mar 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Menoufia University